Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Similar documents
Test Definition: PCDSO Pain Clinic Drug Screen, Urine

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

Laboratory Service Report

The Drug Testing Process. Employer or Practice

INTERPATH LABORATORY, INC. TEST UPDATES

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Urine Drug Testing Methods 3-5

Substance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Pain Medication Management Program Supports Patient Outcomes and Adherence

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

Physician s Reference for Urine and Blood Drug Testing and Interpretation

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

LC Application Note. Dangerous driver?

Fastect II Drug Screen Dipstick Test Training and Certification Program

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

Forensic Toxicology Scope of Testing and Detection Limits

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

Pain Medication Management Program Monitors Patient Compliance

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Schedule of Accreditation

Urine Drug Screening: The Essentials of Interpretation

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

Detection of Drugs-of-Abuse by Tandem Mass Spectrometry.

Drug Adherence Assessment Report

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Urine Opioid Dependency Panel (UODP) 1

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey

European Guidelines for Workplace Drug Testing in UrineandOral fluid

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

DRUGS OF ABUSE

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

nextgen precision Test Report

Keep It Clean. Solid Phase Extraction Solutions for Drugs of Abuse Analysis. Neutral Drugs of Abuse Basic Drugs of Abuse

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Multi-Drug Screen Test

Rapid Alcohol Screening Devices. p19

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

Quest Diagnostics Drug Testing Index Full Year 2015 Tables

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

Controlled Substance Monitoring in the Age of the Opioid Epidemic

2013 Clinical drug and alcohol testing solutions. Product Catalog. CLIA-waived point of care test devices

DRUGS OF ABUSE TEST CUPS 14-DRUG PANEL WITH ADULTERANTS Step by Step Instructions

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Urine drug testing it s not always crystal clear

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

PROFESSIONALISM AND COMMENTARY. Optimizing Urine Drug Testing for Monitoring Medication Compliance in Pain Management

DrugConfirm Advanced Urine Dip Cards.

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

PAML interface maintenance bulletin 5/25/2012 ATTN: INTERFACE DATA MANAGER

ToxCup Drug Screen Cup Step-by Step Instructions

Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Testing for Controlled Substances

10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Evaluation of the Integrated E-Z Split Key Cup II for Rapid Detection of Twelve Drug Classes in Urine

ToxCup Drug Screen Cup (with and without Adulteration Tests) Training and Certification Program

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

T R A I N I N G G U I D E

Drugs of Abuse I Serum

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Case Plan Drug Testing: Myths, Best Practices, and Strategies

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Cutoff levels for hydrocodone in a blood test

Rapid Drug Test Cup Step-by Step Instructions

TITLE: Guidelines for Treatment of Chronic Pain EFFECTIVE DATE: LAST REVISED DATE: LAST REVIEWED DATE:

Why Drug Test in the Retail Industry? 2010 Retail Inventory Shrinkage 3. Employee Theft $16.2B (43.7%)

Validation of an Automated Method to Remove

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Detection of Neonatal Drug Exposure Using Umbilical Cord Tissue and Liquid Chromatography Time-of-Flight Mass Spectrometry

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

DOF. Scheme Description. Drugs in Oral Fluid Scheme

Drug Profiles of Apprehended Drivers in Victoria

EZ-SCREEN CUP Package Insert-I

DAU. Scheme Description. Drugs of Abuse in Urine Proficiency Testing Scheme

Transcription:

Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and documentation required. Specimen Volume: 30 ml Collection Instructions: Collect specimen in the container provided, seal, and submit with the associated documentation to satisfy the legal requirements for chain-of-custody testing. Specimen Type Temperature Time Urine Refrigerated (preferred) 14 days Frozen Ambient 14 days 72 hours Result Codes: Result ID Reporting Name Type Unit LOINC 36262 Alcohol Numeric mg/dl In Process 36253 Amphetamines Numeric ng/ml In Process 36258 Barbiturates Numeric ng/ml In Process 36259 Benzodiazepines Numeric ng/ml In Process 36254 Cocaine Numeric ng/ml In Process 36260 Methadone Numeric ng/ml In Process 36255 Opiates Numeric ng/ml In Process 36256 Phencyclidine Numeric ng/ml In Process 36257 Tetrahydrocannabinol Numeric ng/ml In Process 36261 Chain of Custody Numeric N/A 61727 Oxycodone Numeric ng/ml In Process 36027 Chain of Custody Numeric N/A 36235 Drugs detected: Alphanumeric In Process 36236 Suspect Drug Alphanumeric In Process 36237 Chain of Custody Numeric N/A Document generated July 15, 2014 at 1:42pm CDT Page 1 of 5

Components: Test ID Reporting Name CPT Units CPT Code Always Performed Orderable Separately CDA7X Confirmed Drug Abuse Panel9, CoC, U 1 80104 Yes Yes OXYSX Oxycodone Screen, CoC, U 1 80104 Yes Yes PDSUX Drug Scrn, Prescription/OTC, CoC, U 1 80100 Yes Yes Reflex Tests: Test ID Reporting Name CPT Units CPT Code Always Performed Orderable Separately COCH Chain of Custody Processing 1 99001 Yes No ADLTX Adulterants Survey, CoC, U 1 81005 Yes Yes AMPHX Amphetamines Confirmation, CoC, U 1 82145 No Yes COKEX Cocaine and metabolite Conf, CoC, U 1 82520 No Yes BENZX Benzodiazepines Conf, CoC, U 1 80154 No Yes BARBX Barbiturates Confirmation, CoC, U 1 82205 No Yes MTDNX Methadone Confirmation, CoC, U 1 83840 No Yes PCPX Phencyclidine Confirmation, CoC, U 1 83992 No Yes THCX Carboxy-THC Confirmation, CoC, U 1 80299 No Yes ETOHX Ethanol, CoC, U 1 82055 No No OPATX Opiate Confirmation, CoC, U 1 83925 No Yes OXYCX Oxycodone w/metabolite Conf, CoC, U 1 83925 No Yes Result Codes for Reflex Tests: OPATX 6541 Opiates Immunoassay Screen Numeric 19295-5 OPATX 36213 Codeine-by LC-MS/MS Alphanumeric ng/ml In Process OPATX 36214 Hydrocodone-by LC-MS/MS Alphanumeric ng/ml In Process OPATX 36215 Hydromorphone-by LC-MS/MS Alphanumeric ng/ml In Process OPATX 36216 Oxycodone-by LC-MS/MS Alphanumeric ng/ml In Process Document generated July 15, 2014 at 1:42pm CDT Page 2 of 5

OPATX 36212 Oxymorphone-by LC-MS/MS Alphanumeric ng/ml In Process OPATX 36217 Morphine-by LC-MS/MS Alphanumeric ng/ml In Process OPATX 36218 Opiates Interpretation Alphanumeric In Process OPATX 36219 Chain of Custody Numeric N/A AMPHX 6538 Amphetamines Immunoassay Screen Numeric 19343-3 AMPHX 36128 Amphetamine-by GC/MS Alphanumeric ng/ml In Process AMPHX 36129 Phentermine-by GC/MS Alphanumeric ng/ml In Process AMPHX 36130 Methamphetamine-by GC/MS Alphanumeric ng/ml In Process AMPHX 36131 Pseudoephedrine/Ephedrine-by GC/MS Alphanumeric ng/ml In Process AMPHX 36132 MDA (Ecstasy metabolite)-by GC/MS Alphanumeric ng/ml In Process AMPHX 36133 MDMA (Ecstasy)-by GC/MS Alphanumeric ng/ml In Process AMPHX 36134 Amphetamines Interpretation Alphanumeric In Process AMPHX 36135 Chain of Custody Numeric N/A BARBX 6668 Barbiturates Immunoassay Screen Numeric 19270-8 BARBX 36143 Butalbital-by GC/MS Alphanumeric ng/ml In Process BARBX 36144 Amobarbital-by GC/MS Alphanumeric ng/ml In Process BARBX 36145 Pentobarbital-by GC/MS Alphanumeric ng/ml In Process BARBX 36146 Secobarbital-by GC/MS Alphanumeric ng/ml In Process BARBX 36147 Phenobarbital-by GC/MS Alphanumeric ng/ml In Process BARBX 36148 Barbiturates Interpretation Alphanumeric In Process BARBX 36149 Chain of Custody Numeric N/A BENZX 6670 Benzodiazepines Immunoassay Screen Numeric 14316-4 BENZX 36150 Nordiazepam-by GC/MS Alphanumeric ng/ml In Process BENZX 36151 Oxazepam-by GC/MS Alphanumeric ng/ml In Process BENZX 36152 Lorazepam-by GC/MS Alphanumeric ng/ml In Process BENZX 36153 Temazepam-by GC/MS Alphanumeric ng/ml In Process BENZX 36154 OH-Ethyl-Flurazepam-by GC/MS Alphanumeric ng/ml In Process BENZX 36155 7-NH-Clonazepam-by GC/MS Alphanumeric ng/ml In Process BENZX 36156 Alpha OH-Alprazolam-by GC/MS Alphanumeric ng/ml In Process BENZX 36157 7-NH-Flunitrazepam-by GC/MS Alphanumeric ng/ml In Process BENZX 36158 Alpha OH-Triazolam-by GC/MS Alphanumeric ng/ml In Process Document generated July 15, 2014 at 1:42pm CDT Page 3 of 5

BENZX 36159 Benzodiazepines Interpretation Alphanumeric In Process BENZX 36160 Chain of Custody Numeric N/A COKEX 2903 Cocaine Immunoassay Screen Numeric 3393-6 COKEX 36162 Cocaine-by GC/MS Alphanumeric ng/ml In Process COKEX 36163 Benzoylecgonine-by GC/MS Alphanumeric ng/ml In Process COKEX 36164 Cocaine Interpretation Alphanumeric In Process COKEX 36165 Chain of Custody Numeric N/A ETOHX 30927 Ethanol Immunoassay Screen Numeric mg/dl 5645-7 ETOHX 36187 Ethanol-by GC-FID Numeric mg/dl In Process ETOHX 36188 Ethanol Interpretation Alphanumeric In Process ETOHX 36189 Chain of Custody Numeric N/A MTDNX 21105 Methadone Immunoassay Screen Numeric 16199-2 MTDNX 36208 EDDP-by GC-MS Alphanumeric ng/ml In Process MTDNX 36209 Methadone-by GC-MS Alphanumeric ng/ml In Process MTDNX 36210 Methadone Interpretation Alphanumeric In Process MTDNX 36211 Chain of Custody Numeric N/A PCPX 6672 Phencyclidine Immunoassay Screen Numeric 19659-2 PCPX 36229 Phencyclidine-by GC/MS Alphanumeric ng/ml In Process PCPX 36230 Phencyclidine Interpretation Alphanumeric In Process PCPX 36231 Chain of Custody Numeric N/A THCX 2449 Carboxy-THC Immunoassay Screen Numeric 19415-9 THCX 36238 Carboxy-THC- by GC/MS Alphanumeric ng/ml In Process THCX 36239 Carboxy-THC Interpretation Alphanumeric In Process THCX 36240 Chain of Custody Numeric N/A ADLTX 36121 Creatinine, U Numeric mg/dl In Process ADLTX 36122 Specific Gravity Numeric In Process ADLTX 36123 ph Numeric In Process ADLTX 36124 Oxidants Alphanumeric In Process ADLTX 36125 Nitrites Alphanumeric mcg/ml In Process ADLTX 36126 Comment Alphanumeric In Process OXYCX 36300 Oxycodone Immunoassay Screen Numeric In Process Document generated July 15, 2014 at 1:42pm CDT Page 4 of 5

OXYCX 61728 Oxycodone-by LC-MS/MS Alphanumeric ng/ml In Process OXYCX 35964 Oxymorphone-by LC-MS/MS Alphanumeric ng/ml In Process OXYCX 36023 Oxycodone Interpretation Alphanumeric In Process OXYCX 36028 Chain of Custody Numeric N/A Reference Values: Negative Screening cutoff concentrations Alcohol: 30 mg/dl Amphetamines: 500 ng/ml Barbiturates: 200 ng/ml Benzodiazepines: 200 ng/ml Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/ml Ethanol: 30 mg/dl Methadone: 150 ng/ml Opiates: 300 ng/ml Phencyclidine: 25 ng/ml Tetrahydrocannabinol carboxylic acid: 20 ng/ml This report is intended for use in clinical monitoring or management of patients. It is not intended for use in employment-related testing. Document generated July 15, 2014 at 1:42pm CDT Page 5 of 5